Nuvation Bio
(NYSE) NUVB
Nuvation Bio Financials at a Glance
Market Cap
$1.53B
Revenue (TTM)
$62.90M
Net Income (TTM)
$204.63M
EPS (TTM)
$-0.60
P/E Ratio
-7.35
Dividend
$0.00
Beta (Volatility)
1.38 (Average)
Dividend
$0.00
Beta (Volatility)
1.38 (Average)
Price
$4.45
Volume
141,627
Open
$4.50
Price
$4.45
Volume
141,627
Open
$4.50
Previous Close
$4.45
Daily Range
$4.44 - $4.64
52-Week Range
$1.54 - $9.75
Dividend
$0.00
Beta (Volatility)
1.38 (Average)
Price
$4.45
Volume
141,627
Open
$4.50
Previous Close
$4.45
Daily Range
$4.44 - $4.64
52-Week Range
$1.54 - $9.75
NUVB News
NUVB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nuvation Bio
Industry
Pharmaceuticals
Sector
Health CareEmployees
298
CEO
David T. Hung, MD
Website
www.nuvationbio.comHeadquarters
New York City, NY 10036, US
NUVB Financials
Key Financial Metrics (TTM)
Gross Margin
87%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-53%
Return on Capital
-42%
Return on Assets
-34%
Earnings Yield
-13.61%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.53B
Shares Outstanding
347.60M
Volume
141.63K
Short Interest
0.00%
Avg. Volume
5.32M
Financials (TTM)
Gross Profit
$54.46M
Operating Income
$213.06M
EBITDA
$190.94M
Operating Cash Flow
$173.43M
Capital Expenditure
$354.00K
Free Cash Flow
$173.78M
Cash & ST Invst.
$529.21M
Total Debt
$10.15M
Nuvation Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$41.87M
+633.1%
Gross Profit
$41.44M
+2672.0%
Gross Margin
98.99%
N/A
Market Cap
$1.53B
N/A
Market Cap/Employee
$5.62M
N/A
Employees
273
N/A
Net Income
$36.59M
+26.0%
EBITDA
$29.92M
+39.1%
Quarterly Fundamentals
Net Cash
$519.06M
+5.1%
Accounts Receivable
$19.36M
+18.8%
Inventory
$11.41M
N/A
Long Term Debt
$2.54M
+162.4%
Short Term Debt
$7.60M
-4.3%
Return on Assets
-34.40%
N/A
Return on Invested Capital
-41.57%
N/A
Free Cash Flow
$29.82M
+35.6%
Operating Cash Flow
$29.73M
+35.8%